Camlin Fine Sciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 3,892.25 million compared to INR 3,266.24 million a year ago. Revenue was INR 4,105.43 million compared to INR 3,287.17 million a year ago. Net income was INR 151.3 million compared to INR 142.65 million a year ago. Basic earnings per share from continuing operations was INR 1.16 compared to INR 1.16 a year ago. Diluted earnings per share from continuing operations was INR 1.14 compared to INR 1.03 a year ago.
For the full year, sales was INR 14,120.89 million compared to INR 11,871.03 million a year ago. Revenue was INR 14,451.23 million compared to INR 11,920.87 million a year ago. Net income was INR 606.78 million compared to INR 509.63 million a year ago. Basic earnings per share from continuing operations was INR 4.65 compared to INR 4.13 a year ago. Diluted earnings per share from continuing operations was INR 4.56 compared to INR 3.68 a year ago.